Tylenol maker: possible FDA label change 'unsupported by scientific evidence'
NegativeU.S News

Kenvue, the maker of Tylenol, is pushing back against a proposed FDA label change that suggests a link between acetaminophen use during pregnancy and autism. This comes after a citizen petition raised concerns, but Kenvue argues that extensive scientific research does not support this claim. This matter is significant as it touches on public health and the safety of widely used medications during pregnancy, potentially influencing both consumer behavior and regulatory practices.
— Curated by the World Pulse Now AI Editorial System